AI assistant
MICRO-X LIMITED — Capital/Financing Update 2018
Sep 6, 2018
65388_rns_2018-09-06_ed624d6c-5f7f-4528-b660-088ba9d7f57a.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [128 x 36] intentionally omitted <==
Micro-X Limited, 1284 South Road, Tonsley, Clovelly Park, South Australia, 5042
ABN: 21 153 273 735
Friday 7[th] September 2018
ASX Announcement – MICRO-X LIMITED (ASX: MX1)
Advanced Manufacturing Growth Fund Awards $2.4M Grant to Micro-X
Micro-X Limited (ASX: MX1) is pleased to announce that today it received notification from the Australian Government, Department of Industry, Innovation and Science, of the Company’s successful application for funding under the Advanced Manufacturing Growth Fund Grant.
The Advanced Manufacturing Growth Fund Grant is an Australian Government initiative announced as part of the 2017/18 Federal Budget. The A$47.5M fund was designed to encourage innovation, skills and employment in Advanced Manufacturing in Australia, with applications for grant funding capped at A$2.5M per project.
The award of A$2.4M to Micro-X has been approved to support Micro-X’s investment in plant and equipment in a new state of the art manufacturing site in the Tonsley Innovation District. This expansion will be a co-located facility adjacent to and supplementing Micro-X’s existing manufacturing capability.
Micro-X is investing in growing its manufacturing capability in its core technology x-ray imaging systems in anticipation of the new products currently in design and development. The benefits of this project are improved supply stability, quality, productivity and lower cost of imaging system production through improved in-house manufacturing operations. “This new advanced manufacturing capability will give us much greater capability and help bring our game-changing imaging products to global export markets much faster.” said Managing Director Peter Rowland “We are very proud that the Department of Industry has recognized how this globally unique imaging technology can improve Australia’s high technology exports in medical and security products.”
For further information please contact:
Mr Peter Rowland, Managing Director, Micro-X Limited
Telephone: +61 418 844 981 [email protected] www.micro-x.com
About Micro-X : Micro-X Limited (“ MX1 ”) is an Australian Securities Exchange listed company developing and commercialising a range of highly innovative products based on proprietary carbon nanotube emitter technologies exclusively licensed and sourced from XinRay Systems Inc., a US based technology developer. These technologies enable the miniaturisation of a number of X-ray applications relevant to large global markets.